US · HELP
Cybin Inc. Common Stock
- Sector
- Healthcare · Biotechnology
- Headquarters
- Toronto, ON M5X 1C9
- Website
- cybin.com
Price · as of 2026-07-02
$6.24
Market cap 223.82M
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | $49.99 | ||||
| 2020 | $19.89 | ||||
| 2021 | $58.14 | ||||
| 2022 | $25.46 | $34.26 | |||
| 2023 | $9.20 | ||||
| 2024 | $11.02 | ||||
| 2025 | $8.90 |
USD millions
Line items
USD millions
Line items
USD millions
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | Model Valuation | Core Valuation | Growth | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| HELP | Cybin Inc. Common Stock | $6.24 | 223.82M | — | — | — | — | -2.22 | 1.06 | — | -0.82 | — |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $6.24) − 1 = — (DCF, example).